Pancreatic Cancer Research

ResearcherNanjing Medical UniversityActive in the last 2 years

Wei Peng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5250-760X; OpenAlex author ID A5101979322. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Retraction Note: Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Co-author DOI 10.1007/s12032-025-02701-9↗
  2. Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer. Co-author DOI 10.1016/j.biopha.2016.06.059↗
  3. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer. Co-author DOI 10.1007/s12032-014-0346-4↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jifeng Feng · 2 shared papers, 2014–2025 · strength 0.50
  2. Airen Jiang · 1 shared paper, 2016 · strength 0.12
  3. Wei Gao · 1 shared paper, 2014 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.